The RoverMed CUSP nanocapsule drug delivery platform has unmatched versatility for targeting challenging diseases.
RoverMed technology is the LEADING non-viral solution that delivers therapeutics to the nucleus of the target cell.
RoverMed Nanotechnology will enable the newest class of drugs.

RoverMed Investor:

Technology with Unprecedented Possibilities.

RoverMed has developed the only nancapsule technology capable of delivering drugs directly into the nucleus of infected cells regardless of where these cells are located in the human body.

RoverMed Partner:

CUSP Technology Enables Targeted Drugs to Reach Their Target.

Uniquely provides intact delivery of nucleic acid drug cargos to challenging disease sites using a versatile, precision ligand-targeted platform.